Related references
Note: Only part of the references are listed.IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin
Nengzhi Pang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Synthesis and Evaluation of Novel TLR2 Agonists as Potential Adjuvants for Cancer Vaccines
Benjamin L. Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens
Geoffrey M. Lynn et al.
NATURE BIOTECHNOLOGY (2020)
Third-generation anti-CD19 chimeric antigen receptor T-cells incorporating a TLR2 domain for relapsed or refractory B-cell lymphoma: a phase I clinical trial protocol (ENABLE)
Philip George et al.
BMJ OPEN (2020)
Toll-Like Receptors in Natural Killer Cells and Their Application for Immunotherapy
Ji-Yoon Noh et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
mTORC1 Signaling Controls TLR2-Mediated T-Cell Activation by Inducing TIRAP Expression
Takayuki Imanishi et al.
CELL REPORTS (2020)
CAR-NK cells: A promising cellular immunotherapy for cancer
Guozhu Xie et al.
EBIOMEDICINE (2020)
Constitutively active MyD88/CD40 costimulation enhances expansion and efficacy of chimeric antigen receptor T cells targeting hematological malignancies
Matthew R. Collinson-Pautz et al.
LEUKEMIA (2019)
Toll-Like Receptor 7 Activation Enhances CD8+T Cell Effector Functions by Promoting Cellular Glycolysis
Qian Li et al.
FRONTIERS IN IMMUNOLOGY (2019)
The Role of TLRs in Anti-cancer Immunity and Tumor Rejection
Zuzanna Urban-Wojciuk et al.
FRONTIERS IN IMMUNOLOGY (2019)
Costimulation through TLR2 Drives Polyfunctional CD8+ T Cell Responses
Fiamma Salerno et al.
JOURNAL OF IMMUNOLOGY (2019)
Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerations
Robert Weinkove et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2019)
Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T Cells
Y. Lai et al.
LEUKEMIA (2018)
MYD88 L265P Mutation in Lymphoid Malignancies
Xinfang Yu et al.
CANCER RESEARCH (2018)
A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia
Jianyu Weng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Mechanisms of BCG immunotherapy and its outlook for bladder cancer
Caroline Pettenati et al.
NATURE REVIEWS UROLOGY (2018)
Toll-Like Receptors, Associated Biological Roles, and Signaling Networks in Non-Mammals
Li Nie et al.
FRONTIERS IN IMMUNOLOGY (2018)
TLR Stimulation during T-cell Activation Lowers PD-1 Expression on CD8+ T Cells
Christopher D. Zahm et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor Models
Melinda Mata et al.
CANCER DISCOVERY (2017)
Limb proportions show developmental plasticity in response to embryo movement
A. S. Pollard et al.
SCIENTIFIC REPORTS (2017)
A Synthetic CD8α:MyD88 Coreceptor Enhances CD8+ T-cell Responses to Weakly Immunogenic and Lowly Expressed Tumor Antigens
Sabina Kaczanowska et al.
CANCER RESEARCH (2017)
Toll like Receptor 2 engagement on CD4+ T cells promotes TH9 differentiation and function
Ahmad Faisal Karim et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice
G. Knittel et al.
BLOOD (2016)
Direct TLR-2 Costimulation Unmasks the Proinflammatory Potential of Neonatal CD4+ T Cells
Brian D. Sinnott et al.
JOURNAL OF IMMUNOLOGY (2016)
Toll-Like Receptor 11 (TLR11) Interacts with Flagellin and Profilin through Disparate Mechanisms
Hirotsugu Hatai et al.
PLOS ONE (2016)
Triggering Through Toll-like Receptor 2 Limits Chronically Stimulated T-helper Type 1 Cells From Undergoing Exhaustion
Sathi Babu Chodisetti et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Systemic injection of TLR1/2 agonist improves adoptive antigen-specific T cell therapy in glioma-bearing mice
Yufei Zhang et al.
CLINICAL IMMUNOLOGY (2014)
TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals
Minou Adib-Conquy et al.
IMMUNOLOGY AND CELL BIOLOGY (2014)
Human TLR10 is an anti-inflammatory pattern-recognition receptor
Marije Oosting et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Toll-like receptor signaling pathways
Takumi Kawasaki et al.
FRONTIERS IN IMMUNOLOGY (2014)
Adjuvants That Improve the Ratio of Antigen-Specific Effector to Regulatory T Cells Enhance Tumor Immunity
Rachel Perret et al.
CANCER RESEARCH (2013)
Distinct signaling. pathways regulate TLR2 co-stimulatory function in human T cells
Nicole M. Chapman et al.
CELLULAR SIGNALLING (2013)
Recognition of Profilin by Toll-like Receptor 12 Is Critical for Host Resistance to Toxoplasma gondii
A. Alicia Koblansky et al.
IMMUNITY (2013)
Cooperation of TLR12 and TLR11 in the IRF8-Dependent IL-12 Response to Toxoplasma gondii Profilin
Megan Raetz et al.
JOURNAL OF IMMUNOLOGY (2013)
TLR agonists: our best frenemy in cancer immunotherapy
Sabina Kaczanowska et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Molecular mechanisms of T cell co-stimulation and co-inhibition
Lieping Chen et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Prolonged subcutaneous administration of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced hematologic malignancies
Brenda J. Weigel et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Cutting Edge: TLR13 Is a Receptor for Bacterial RNA
Asa Hidmark et al.
JOURNAL OF IMMUNOLOGY (2012)
Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
Taro Kawai et al.
IMMUNITY (2011)
In vivo anti- and pro-tumour activities of the TLR2 ligand FSL-1
Kazuto Kiura et al.
IMMUNOBIOLOGY (2011)
TLR2 Stimulation Drives Human Naive and Effector Regulatory T Cells into a Th17-Like Phenotype with Reduced Suppressive Function
Mukanthu H. Nyirenda et al.
JOURNAL OF IMMUNOLOGY (2011)
TLR1/TLR2 Agonist Induces Tumor Regression by Reciprocal Modulation of Effector and Regulatory T Cells
Yi Zhang et al.
JOURNAL OF IMMUNOLOGY (2011)
The Structural Biology of Toll-like Receptors
Istvan Botos et al.
STRUCTURE (2011)
Amplifying TLR-MyD88 Signals within Tumor-Specific T Cells Enhances Antitumor Activity to Suboptimal Levels of Weakly Immunogenic Tumor Antigens
Degui Geng et al.
CANCER RESEARCH (2010)
Toll-like Receptor 2 Signaling in CD4+ T Lymphocytes Promotes T Helper 17 Responses and Regulates the Pathogenesis of Autoimmune Disease
Joseph M. Reynolds et al.
IMMUNITY (2010)
Differential but Direct Abolishment of Human Regulatory T Cell Suppressive Capacity by Various TLR2 Ligands
Hans-Heinrich Oberg et al.
JOURNAL OF IMMUNOLOGY (2010)
A critical role for direct TLR2-MyD88 signaling in CD8 T-cell clonal expansion and memory formation following vaccinia viral infection
Michael Quigley et al.
BLOOD (2009)
The contribution of direct TLR signaling to T cell responses
Adeeb H. Rahman et al.
IMMUNOLOGIC RESEARCH (2009)
Activated Human Neonatal CD8(+) T Cells Are Subject to Immunomodulation by Direct TLR2 or TLR5 Stimulation
Mark McCarron et al.
JOURNAL OF IMMUNOLOGY (2009)
TLR2 Engagement on CD8 T Cells Enables Generation of Functional Memory Cells in Response to a Suboptimal TCR Signal
Blandine C. Mercier et al.
JOURNAL OF IMMUNOLOGY (2009)
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Sunhwa Kim et al.
NATURE (2009)
Modulation of adaptive immunity with Toll-like receptors
Santhakumar Manicassamy et al.
SEMINARS IN IMMUNOLOGY (2009)
Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity
Nicole Asprodites et al.
FASEB JOURNAL (2008)
TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity
Ulrich Zaehringer et al.
IMMUNOBIOLOGY (2008)
Increased expression of Toll-like receptor 5 during progression of cervical neoplasia
W. Y. Kim et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease
Masayuki Fukata et al.
JOURNAL OF IMMUNOLOGY (2008)
Mycoplasma infection suppresses p53, activates NF-κB and cooperates with oncogenic Ras in rodent fibroblast transformation
D. Y. Logunov et al.
ONCOGENE (2008)
Cutting edge: TLR2 directly triggers Th1 effector functions
Takayuki Imanishi et al.
JOURNAL OF IMMUNOLOGY (2007)
Cancer relapse under chemotherapy: Why TLR2/4 receptor agonists can help
Ricardo P. Garay et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro
Joanna M. Ilvesaro et al.
PROSTATE (2007)
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Development of TLR9 agonists for cancer therapy
Arthur M. Krieg
JOURNAL OF CLINICAL INVESTIGATION (2007)
Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling
Bo Huang et al.
CANCER RESEARCH (2007)
Autophagy-dependent viral recognition by plasmacytoid dendritic cells
Heung Kyu Lee et al.
SCIENCE (2007)
Expression and function of Toll-like receptors in T lymphocytes
Dieter Kabelitz
CURRENT OPINION IN IMMUNOLOGY (2007)
Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia
D. E. Spaner et al.
LEUKEMIA (2007)
Human effector CD8+ T lymphocytes express TLR3 as a functional coreceptor
Julie Tabiasco et al.
JOURNAL OF IMMUNOLOGY (2006)
TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation
Anne Cottalorda et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Toll-like receptor 2 signaling modulates the functions of CD4+CD25+ regulatory T cells
HY Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis
A Mansson et al.
RESPIRATORY RESEARCH (2006)
Direct costimulatory effect of TLR3 ligand poly(I:C) on human γδ T lymphocytes
D Wesch et al.
JOURNAL OF IMMUNOLOGY (2006)
Toll-like receptor 2 controls expansion and function of regulatory T cells
RPM Sutmuller et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma
A Carpentier et al.
NEURO-ONCOLOGY (2006)
Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA
GM Barton et al.
NATURE IMMUNOLOGY (2006)
Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells
NK Crellin et al.
JOURNAL OF IMMUNOLOGY (2005)
TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements
T Nishiya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Direct stimulation of human T cells via TLR5 and TLR7/8:: Flagellin and R-848 up-regulate proliferation and IFN-γ production by memory CD4+ T cells
G Caron et al.
JOURNAL OF IMMUNOLOGY (2005)
Human lung cancer cells express functionally active Toll-like receptor 9
D Droemann et al.
RESPIRATORY RESEARCH (2005)
Imiquimod for the treatment of skin cancer
CA Burns et al.
DERMATOLOGIC CLINICS (2005)
Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells
MG Netea et al.
JOURNAL OF IMMUNOLOGY (2004)
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
F Heil et al.
SCIENCE (2004)
TLR2 is expressed on activated T cells as a costimulatory receptor
M Komai-Koma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Inhibition of NF-κB in cancer cells converts inflammation-induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression
JL Luo et al.
CANCER CELL (2004)
Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease
V Sobek et al.
ARTHRITIS RESEARCH & THERAPY (2004)
The IKKNF-kappa B system: A treasure trove for drug development
M Karin et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Toll-like receptor ligands directly promote activated CD4+ T cell survival
AE Gelman et al.
JOURNAL OF IMMUNOLOGY (2004)
Simultaneous blocking of human toll-like receptors 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Guerin peptidoglycan
J Uehori et al.
INFECTION AND IMMUNITY (2003)
Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide
I Caramalho et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
The use of Toll-like receptor-7 agonist in the treatment of basal cell carcinoma: an overview
E Stockfleth et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors
T Horng et al.
NATURE (2002)
Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion
JH Harmey et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides
V Hornung et al.
JOURNAL OF IMMUNOLOGY (2002)
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
L Alexopoulou et al.
NATURE (2001)
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
F Hayashi et al.
NATURE (2001)
A Toll-like receptor recognizes bacterial DNA
H Hemmi et al.
NATURE (2000)
The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors
A Ozinsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
The IL-I receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense
LAJ O'Neill et al.
IMMUNOLOGY TODAY (2000)
Share Paper
